Inspirna

Provider of drug research & development services for oncology treatment

placeNew York City, New York, United States calendar_todayFounded 2010 groups11 employees language inspirna.com

Innovation

13 patent families (10 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 3,115 times.

YearFilings
20191
20203
20216
20227
20237
20248
20258

Investor mix

12 investors on record; lead investors include Sands Capital, Vivo Capital.

Investor typeCountShare
Venture capital542%
Private equity217%
Angel & family office18%
Bank & private debt18%
Other / undisclosed325%
Coming soon